Skip to main content
Clinical Trials/CTRI/2021/04/033068
CTRI/2021/04/033068
Recruiting
未知

A Prospective observational study to establish the duration of persistence of replication-competent SARS-CoV-2 in oncology patients with COVID-19 on chemotherapy

Tata Memorial Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: C00-D49- Neoplasms
Sponsor
Tata Memorial Hospital
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Oncology patients admitted with RT\-PCR confirmed COVID\-19 illness
  • 2\. Age 1 to 80 years
  • 3\. Patients willing to consent for additional blood and nasopharyngeal swabs.

Exclusion Criteria

  • 1\. ICU patients unable to give nasopharyngeal swab or blood sample for study proposes
  • 2\. Patients with other inter\-current bacterial viral respiratory infections.
  • 3\. Patients in palliative therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials